Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment is important for better hair regrowth in elderly women with hair loss.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

Iron deficiency is linked to hair loss in CTE patients.

People with chronic hair loss may have a higher chance of Vitamin B12 deficiency.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

Low levels of iron and vitamin D might be linked to chronic hair loss in women.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Trichoscopic features can help dermatologists distinguish between female pattern hair loss and chronic telogen effluvium.

A simple method using the wash test and dermatoscopy can help differentiate between two hair loss conditions, androgenetic alopecia and chronic telogen effluvium.

A simple wash test can help differentiate between two types of hair loss, and dermatoscopy should be used for further clarification.

A simple method using the wash test and dermatoscopy can help differentiate between two hair loss conditions, androgenetic alopecia and chronic telogen effluvium.

People with chronic hair shedding had much lower vitamin D levels compared to healthy people.

Some people with chronic hair loss may have thyroid autoimmunity.

People with chronic hair loss often have lower Vitamin B12 levels.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Hair is thinner near the scalp in acute hair shedding conditions.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.

A supplement with Serenoa repens improved hair loss in a patient.